Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Empasiprubart Versus Placebo in Chronic Inflammatory Demyelinating Polyradiculoneuropathy: EMNERGIZE Phase Three Study Design

Author:Rinaldi, Simon   Brannagan, Thomas   Doneddu, Pietro Emiliano   Gable, Karissa   Stettner, Mark   Querol, Luis   Patel, Reena   Haddad, Hafedh   Van de Steen, Olivier   Budding, Kevin   Van de Walle, Inge   Ellor, Susan   Markov, Martin   Allen, Jeffrey   

Session Name:P1: Neuromuscular and Clinical Neurophysiology (EMG): Autoimmune Neuropathies  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P1.021  

Author Institution:University of Oxford, Oxford, United Kingdom  Columbia University, New York, NY  IRCCS Humanitas Research Hospital, Milan, Italy  Duke University, Durham, NC  University Medicine Essen, Essen, Germany  Hospital de la Santa Creu i Sant Pau, Barcelona, Spain  argenx, Ghent, Belgium  University of Minnesota, Minneapolis, MN  

Variants of Uncertain Significance in Patients with Cervical Artery Dissection

Author:DiMeglio, David   Ferguson, Robert   Thomas, Matthew   Aldridge, Chad   Amos, Kaitlyn   Worrall, Bradford   Southerland, Andrew   

Session Name:P1: Cerebrovascular Disease and Interventional Neurology: Stroke Secondary to Vasculopathy or Thrombosis  

Topic:Cerebrovascular Disease and Interventional Neurology  

Program Number:P1.022  

Author Institution:University of Virginia, McLean, VA  University of Virginia, VA  University of Virginia, Charlottesville, VA  

Empasiprubart vs Immunoglobulin in Chronic Inflammatory Demyelinating Polyradiculoneuropathy: EMVIGORATE Phase Three Study Design

Author:Rinaldi, Simon   Brannagan, Thomas   Doneddu, Pietro Emiliano   Gable, Karissa   Stettner, Mark   Van de Steen, Olivier   Budding, Kevin   Van de Walle, Inge   Ellor, Susan   Markov, Martin   Allen, Jeffrey   

Session Name:P1: Neuromuscular and Clinical Neurophysiology (EMG): Autoimmune Neuropathies  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P1.022  

Author Institution:University of Oxford, Oxford, United Kingdom  Columbia University, New York, NY  IRCCS Humanitas Research Hospital, Milan, Italy  Duke University, Durham, NC  University Medicine Essen, Essen, Germany  argenx, Ghent, Belgium  University of Minnesota, Minneapolis, MN  

Exposure-response (ER) and Clinical Trial Simulations for Efficacy of Ecopipam in Adults and Pediatrics with Tourette’s Syndrome (TS)

Author:Wanaski, Stephen   Freidy, Soha   Rice, Patricia   Cunniff, Timothy   Schmith, Virginia   

Session Name:P2: Movement Disorders: Hyperkinetic Movement Disorders 1  

Topic:Movement Disorders  

Program Number:P2.001  

Author Institution:Paragon Biosciences, LLC, Chicago, IL  Allucent, NC  Emalex Biosciences, Inc., IL  Paragon Biosciences, LLC, IL  Schmith PK/PD Consulting, LLC, Cocoa Beach, FL  

Diagnostic Yield of Rapid Whole Genome Sequencing in Hospitalized Adults with Unexplained Neurological Manifestations

Author:Amanat, Manouchehr   Toledano, Michel   Schimmenti, Lisa   Pichurin, Pavel   Deyle, David   Jabs, Ethylin   Dhamija, Radhika   

Session Name:P2: General Neurology: Miscellaneous 2  

Topic:General Neurology  

Program Number:P2.001  

Author Institution:Mayo Clinic, Rochester, MN  Mayo Clinic, MN